ARA-290 10 mg research-grade lyophilized peptide powder in a glass vial. Studied in innate repair receptor (IRR) signaling, neuroprotection, anti-inflammatory pathways and tissue-protective research models.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Form
Lyophilized peptide powder
Content
10 mg ARA-290 per vial
Packaging
Glass vial with sterile closure
Storage
Store lyophilized at 2–8 °C, desiccated and protected from light
Molecular Formula
C51H84N16O21
Molecular Weight
≈ 1257.3 g·mol⁻¹
Sequence (pyroglutamate)
Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-NH2
For diluting lyophilized peptide powders, you need a suitable solvent such as bacteriostatic water (BAC). See
Bacteriostatic water – 10 ml .
Research Overview
ARA-290 (Cibinetide) is an 11-amino-acid peptide engineered from erythropoietin (EPO) that selectively targets the innate repair receptor (IRR) rather than the classical erythropoietin receptor. In laboratory settings it is used to explore tissue-protective, neuroprotective and anti-inflammatory signaling pathways in diverse experimental models.
Primary Research Areas
-
Innate Repair Receptor (IRR) Signaling: Used in models probing IRR activation, downstream tissue-protective cascades and cell-survival pathways.
-
Neuroprotection & Neuropathy Models: Studied in experimental systems focused on small-fiber neuropathy, nerve injury, neuroinflammation and neural repair signaling.
-
Anti-inflammatory & Tissue-Protective Pathways: Frequently used to investigate cytokine modulation, inflammatory signaling and tissue-protection frameworks under metabolic or ischemic stress.
-
Cytoprotection & Cellular Stress Response: Included in research on cytoprotective mechanisms, organ-protection models and recovery of cells exposed to oxidative or metabolic challenge.
